News Home

Merck & Co., Inc. (MRK) Stock: Do Analysts Think You Should Sell?

Monday, September 20, 2021 11:33 AM | InvestorsObserver Analysts
Merck & Co., Inc. (MRK) Stock: Do Analysts Think You Should Sell?

Analysts who follow Merck & Co., Inc. (MRK) on average expect it to gain 27.17% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Merck & Co., Inc. an Analyst Ranking of 29, which means it ranks higher than 29 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4
Wall Street analysts are rating MRK a Buy today. Find out what this means to you and get the rest of the rankings on MRK!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Merck & Co., Inc. Stock Today?

Merck & Co., Inc. (MRK) stock has risen 1.12% while the S&P 500 is lower by -1.55% as of 11:25 AM on Monday, Sep 20. MRK is higher by $0.80 from the previous closing price of $71.70 on volume of 5,034,941 shares. Over the past year the S&P 500 has risen 33.01% while MRK is lower by -8.54%. MRK earned $2.19 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.06. Click Here to get the full Stock Report for Merck & Co., Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App